Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 5;26(5):2307.
doi: 10.3390/ijms26052307.

Molecular Underpinnings of Brain Metastases

Affiliations
Review

Molecular Underpinnings of Brain Metastases

Maria A Jacome et al. Int J Mol Sci. .

Abstract

Brain metastases are the most commonly diagnosed type of central nervous system tumor, yet the mechanisms of their occurrence are still widely unknown. Lung cancer, breast cancer, and melanoma are the most common etiologies, but renal and colorectal cancers have also been described as metastasizing to the brain. Regardless of their origin, there are common mechanisms for progression to all types of brain metastases, such as the creation of a suitable tumor microenvironment in the brain, priming of tumor cells, adaptations to survive spreading in lymphatic and blood vessels, and development of mechanisms to penetrate the blood-brain barrier. However, there are complex genetic and molecular interactions that are specific to every type of primary tumor, making the understanding of the metastatic progression of tumors to the brain a challenging field of study. In this review, we aim to summarize current knowledge on the pathophysiology of brain metastases, from specific genetic characteristics of commonly metastatic tumors to the molecular and cellular mechanisms involved in progression to the central nervous system. We also briefly discuss current challenges in targeted therapies for brain metastases and how there is still a gap in knowledge that needs to be overcome to improve patient outcomes.

Keywords: brain metastases; breast cancer; central nervous system; genetic features; lung cancer; melanoma; molecular mechanisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Genetic features of brain metastases in different cancer types.
Figure 2
Figure 2
Molecular mechanisms of brain metastatic progression.

References

    1. Ostrom Q.T., Wright C.H., Barnholtz-Sloan J.S. Handbook of Clinical Neurology. Elsevier; Amsterdam, The Netherlands: 2018. Brain Metastases: Epidemiology; pp. 27–42. - PubMed
    1. Sacks P., Rahman M. Epidemiology of Brain Metastases. Neurosurg. Clin. N. Am. 2020;31:481–488. doi: 10.1016/j.nec.2020.06.001. - DOI - PubMed
    1. Cagney D.N., Martin A.M., Catalano P.J., Redig A.J., Lin N.U., Lee E.Q., Wen P.Y., Dunn I.F., Bi W.L., Weiss S.E., et al. Incidence and Prognosis of Patients with Brain Metastases at Diagnosis of Systemic Malignancy: A Population-Based Study. Neuro Oncol. 2017;19:1511–1521. doi: 10.1093/neuonc/nox077. - DOI - PMC - PubMed
    1. Davis F.G., Dolecek T.A., McCarthy B.J., Villano J.L. Toward Determining the Lifetime Occurrence of Metastatic Brain Tumors Estimated from 2007 United States Cancer Incidence Data. Neuro Oncol. 2012;14:1171–1177. doi: 10.1093/neuonc/nos152. - DOI - PMC - PubMed
    1. Fox B.D., Cheung V.J., Patel A.J., Suki D., Rao G. Epidemiology of Metastatic Brain Tumors. Neurosurg. Clin. N. Am. 2011;22:1–6. doi: 10.1016/j.nec.2010.08.007. - DOI - PubMed

LinkOut - more resources